Biomed Realty Trust (BMR) 23.81 $BMR Uptrend Ca
Post# of 273254
Posted On: 09/08/2016 1:22:53 AM
Biomed Realty Trust (BMR) 23.81 $BMR
Uptrend Call Working As BioMed Realty Trust Stock Rises 21.1% (BMR)
Comtex SmarTrend(R) - Fri Sep 02, 1:55PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 12 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
Shares of BMR Up 21.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 26, 1:22AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 11 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
21.1% Return Seen to Date on SmarTrend BioMed Realty Trust Call (BMR)
Comtex SmarTrend(R) - Thu Aug 18, 1:28AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 11 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Up 21.1% Since SmarTrend Uptrend Call (BMR)
Comtex SmarTrend(R) - Tue Jun 07, 12:48AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 9 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Shares Up 21.1% Since SmarTrend's Buy Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 12, 1:56PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Has Returned 21.1% Since SmarTrend Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 05, 1:36PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
Blackstone completes acquisition of BioMed Realty Trust
M2 - Thu Feb 04, 7:01AM CST
BioMed Realty Trust, Inc. (NYSE: BMR) has completed its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P, valued at USD8.0 billion, the company said. Pursuant to the transaction, holders of shares of common stock of BioMed Realty will be entitled to receive USD23.8239 in cash, without interest, in exchange for each share of common stock they own. Morgan Stanley & Co. LLC acted as lead financial advisor to BioMed Realty, with Raymond James & Associates, Inc. also acting as a financial advisor in connection with this transaction. Latham & Watkins LLP acted as BioMed Realty's legal advisor. Eastdil Secured Group of Wells Fargo Securities LLC, Citigroup Global Markets Inc., JP Morgan Securities LLC, Bank of America Merrill Lynch and Goldman Sachs acted as Blackstone's financial advisors in connection with the transaction. Simpson Thacher & Bartlett LLP acted as legal advisor to Blackstone. BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. Blackstone has approximately USD92 billion in investor capital under management. Blackstone's real estate portfolio includes hotel, office, retail, industrial and residential properties in the US, Europe, Asia and Latin America.
BMR: 23.81 (+0.04), WFC: 49.77 (-0.22), MS: 31.69 (-0.06)
United Kingdom & Ireland Laboratories (All Sectors) Project Reporting Package Report 2016
M2 - Thu Jan 28, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/vxf8ml/laboratories_all) has announced the addition of the "Laboratories (All Sectors) Project Reporting Package - United Kingdom & Ireland" report to their offering. This laboratories capex project reporting package covers projects associated with the pharmaceutical/biotech throughout the UK and Ireland. All laboratories projects sit within the main process sectors and cover activities such as QA/QC, R&D and new product development (NPD). Projects range from upgrades and modifications to expansions and complete new builds, all with a breadth of scope to include a wide range of equipment as well as associated building and services aspects such as cleanrooms, HVAC, utilities and effluent treatment. One of the most important features of this project reporting is the inclusion of key decision makers which includes contacts with roles encompassing: - External consultants - Technology providers - Design - Engineering - EPC contractors - Equipment specification & selection - Procurement - Planning - Project management - Operations management Within this package there are 59 project reports which include: - Capital Expenditure > 1m - Scheduled to enter procurement phase during 2016 - Project Types: - - New Builds - - Expansions - - Upgrades - - Modifications - Facility Types - - Manufacturing Processes - - Product Development / R&D - - Controlled Storage - - Site Utilities Key Topics Covered: The following information is provided for each project: 1. Company Information - Name - Address - Phone & Fax - Web Site 2. Project Information - Sensitivity - Description - Product Type - Project Location - Project Region - Value - Status 3. Contacts 4. Schedule 5. Notes - Background - Project - Scope - Process Companies Mentioned - 4D Pharma plc - AB Agri Ltd - AarhusKarlshamn UK Ltd - Alcohols Ltd - Babraham Institute - Bartholomews Agri Food Ltd - BioMed Realty Trust Inc - Cara Partners Ltd - Catalent Pharma Solutions Ltd - Cellulac Ltd - Chinook Sciences Ltd - CooperVision Manufacturing Ltd - Cork County Council - HMG Paints Ltd - Harper Adams University - Hologic Ltd - Indivior UK Ltd - Industrial Chemicals Group Ltd - Institute for Animal Health - Keele University Science & Business Park - Merck Sharp & Dohme Ltd - Microbiological Solutions Ltd - National Centre for Food Manufacturing - Oxford Brookes University - Pochin's Ltd - Public Health England - Quantum Pharmaceutical Ltd - Royal Free Hospital NHS Trust - Sandwell & West Birmingham Hospitals - Stryker Orthopaedics - Swallowfield plc - Syngenta UK Ltd - The Centre for Process Innovation - Treatt plc - UCB Pharma Ltd For more information visit http://www.researchandmarkets.com/research/vx...tories_all
BMR: 23.81 (+0.04), MRK: 62.87 (-0.37), HOLX: 38.67 (+0.17)
Blackstone Completes Acquisition Of BioMed Realty Trust
PR Newswire - Wed Jan 27, 1:48PM CST
BioMed Realty Trust, Inc. (NYSE: BMR) (the "Company"
announced today the completion of its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P. The total transaction value is approximately $8 billion.
BMR: 23.81 (+0.04)
Uptrend Call Working As BioMed Realty Trust Stock Rises 21.1% (BMR)
Comtex SmarTrend(R) - Fri Sep 02, 1:55PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 12 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
Shares of BMR Up 21.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 26, 1:22AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 11 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
21.1% Return Seen to Date on SmarTrend BioMed Realty Trust Call (BMR)
Comtex SmarTrend(R) - Thu Aug 18, 1:28AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 11 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Up 21.1% Since SmarTrend Uptrend Call (BMR)
Comtex SmarTrend(R) - Tue Jun 07, 12:48AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 9 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Shares Up 21.1% Since SmarTrend's Buy Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 12, 1:56PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Has Returned 21.1% Since SmarTrend Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 05, 1:36PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
Blackstone completes acquisition of BioMed Realty Trust
M2 - Thu Feb 04, 7:01AM CST
BioMed Realty Trust, Inc. (NYSE: BMR) has completed its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P, valued at USD8.0 billion, the company said. Pursuant to the transaction, holders of shares of common stock of BioMed Realty will be entitled to receive USD23.8239 in cash, without interest, in exchange for each share of common stock they own. Morgan Stanley & Co. LLC acted as lead financial advisor to BioMed Realty, with Raymond James & Associates, Inc. also acting as a financial advisor in connection with this transaction. Latham & Watkins LLP acted as BioMed Realty's legal advisor. Eastdil Secured Group of Wells Fargo Securities LLC, Citigroup Global Markets Inc., JP Morgan Securities LLC, Bank of America Merrill Lynch and Goldman Sachs acted as Blackstone's financial advisors in connection with the transaction. Simpson Thacher & Bartlett LLP acted as legal advisor to Blackstone. BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. Blackstone has approximately USD92 billion in investor capital under management. Blackstone's real estate portfolio includes hotel, office, retail, industrial and residential properties in the US, Europe, Asia and Latin America.
BMR: 23.81 (+0.04), WFC: 49.77 (-0.22), MS: 31.69 (-0.06)
United Kingdom & Ireland Laboratories (All Sectors) Project Reporting Package Report 2016
M2 - Thu Jan 28, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/vxf8ml/laboratories_all) has announced the addition of the "Laboratories (All Sectors) Project Reporting Package - United Kingdom & Ireland" report to their offering. This laboratories capex project reporting package covers projects associated with the pharmaceutical/biotech throughout the UK and Ireland. All laboratories projects sit within the main process sectors and cover activities such as QA/QC, R&D and new product development (NPD). Projects range from upgrades and modifications to expansions and complete new builds, all with a breadth of scope to include a wide range of equipment as well as associated building and services aspects such as cleanrooms, HVAC, utilities and effluent treatment. One of the most important features of this project reporting is the inclusion of key decision makers which includes contacts with roles encompassing: - External consultants - Technology providers - Design - Engineering - EPC contractors - Equipment specification & selection - Procurement - Planning - Project management - Operations management Within this package there are 59 project reports which include: - Capital Expenditure > 1m - Scheduled to enter procurement phase during 2016 - Project Types: - - New Builds - - Expansions - - Upgrades - - Modifications - Facility Types - - Manufacturing Processes - - Product Development / R&D - - Controlled Storage - - Site Utilities Key Topics Covered: The following information is provided for each project: 1. Company Information - Name - Address - Phone & Fax - Web Site 2. Project Information - Sensitivity - Description - Product Type - Project Location - Project Region - Value - Status 3. Contacts 4. Schedule 5. Notes - Background - Project - Scope - Process Companies Mentioned - 4D Pharma plc - AB Agri Ltd - AarhusKarlshamn UK Ltd - Alcohols Ltd - Babraham Institute - Bartholomews Agri Food Ltd - BioMed Realty Trust Inc - Cara Partners Ltd - Catalent Pharma Solutions Ltd - Cellulac Ltd - Chinook Sciences Ltd - CooperVision Manufacturing Ltd - Cork County Council - HMG Paints Ltd - Harper Adams University - Hologic Ltd - Indivior UK Ltd - Industrial Chemicals Group Ltd - Institute for Animal Health - Keele University Science & Business Park - Merck Sharp & Dohme Ltd - Microbiological Solutions Ltd - National Centre for Food Manufacturing - Oxford Brookes University - Pochin's Ltd - Public Health England - Quantum Pharmaceutical Ltd - Royal Free Hospital NHS Trust - Sandwell & West Birmingham Hospitals - Stryker Orthopaedics - Swallowfield plc - Syngenta UK Ltd - The Centre for Process Innovation - Treatt plc - UCB Pharma Ltd For more information visit http://www.researchandmarkets.com/research/vx...tories_all
BMR: 23.81 (+0.04), MRK: 62.87 (-0.37), HOLX: 38.67 (+0.17)
Blackstone Completes Acquisition Of BioMed Realty Trust
PR Newswire - Wed Jan 27, 1:48PM CST
BioMed Realty Trust, Inc. (NYSE: BMR) (the "Company"
announced today the completion of its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P. The total transaction value is approximately $8 billion. BMR: 23.81 (+0.04)
(0)
(0)Scroll down for more posts ▼